InflammX
View On Demand

Improving the vision of people with Dry AMD and Diabetic Retinopathy

About the Event


InflammX is in the process of finalizing financing to move their program for Xiflam into clinical trials. But, there is still an opportunity for those interested in co-investing.

In proof-of-concept testing, InflammX has demonstrated Xiflam’s ability to restore normal biology to the dysregulated inflammasomes which are involved in Dry Age-Related Macular Degeneration and Diabetic Retinopathy. Orally administered Xiflam is supported by a safety database of more than 1000 points showing the drug to be well tolerated with no safety concerns.

Join our webinar to hear directly from InflammX CEO, Dr. Brian Levy as he talks about the opportunity to co-invest in the company and help improve the vision of people with Dry AMD and Diabetic Retinopathy.

View On-Demand Webinar


SHARE THIS EVENT
Share on facebook
Share on twitter
Share on linkedin

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.